특발성 문맥압 항진증 환자에서 반복적인 간문맥과 상장간막정맥 혈전증Recurrent portal and superior mesenteric vein thrombosis in a patient with idiopathic portal hypertension
- Other Titles
- Recurrent portal and superior mesenteric vein thrombosis in a patient with idiopathic portal hypertension
- Authors
- 임금남; 손주현; 김현수; 김태엽; 은창수; 전용철; 한동수
- Issue Date
- Mar-2008
- Publisher
- 대한내과학회
- Keywords
- 특발성 문맥압 항진증; 간문맥 혈전증; 상장간막정맥 혈전증; 항응고요법; Anticoagulation; Idiopathic portal hypertension; Portal vein thrombosis; Superior mesenteric vein thrombosis
- Citation
- 대한내과학회지, v.75, no.3, pp 337 - 342
- Pages
- 6
- Indexed
- KCI
- Journal Title
- 대한내과학회지
- Volume
- 75
- Number
- 3
- Start Page
- 337
- End Page
- 342
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/178833
- ISSN
- 1738-9364
2289-0769
- Abstract
- Idiopathic portal hypertension (IPH) is characterized by portal hypertension and splenomegaly without portal vein obstruction or significant liver disease. Although IPH may occasionally be accompanied by portal vein thrombosis (PVT) and extrahepatic portal vein thrombosis (EHPVT), recurrent PVT and EHPVT are very rare in IPH. Herein, we report the case of a 30-year-old male who developed IPH with recurrent PVT and EHPVT. Eleven years earlier, the patient had undergone splenectomy and endoscopic sclerotherapy due to hypersplenism and esophageal variceal bleeding, respectively. Ten years earlier, the patient had suffered recurrent esophageal variceal bleeding, which was treated via band ligation, and was diagnosed with IPH via portography and liver biopsy. Then, 8 years prior to presentation, the patient complained of acute abdominal pain and was diagnosed with PVT and EHPVT. After a 6-month course of anticoagulation therapy, the PVT and EHPVT resolved completely. However, 8 years later, he complained again of abdominal pain and was diagnosed with recurrent PVT and EHPVT. (Korean J Med 75:337-342, 2008)
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.